|
|
|
Insider
Information: |
Macdonald Guy |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
42,000 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$65,280 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
42,000 |
|
|
Total
Value |
$65,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
9.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Idenix Pharmaceuticals Inc |
IDIX |
Executive VP, Operations |
2004-07-27 |
10,000 |
2004-07-27 |
0 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2014-02-10 |
0 |
Premium* |
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
32,000 |
2016-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IDIX |
Idenix Pharmaceuticals In... |
Executive VP, Operations |
|
2004-07-27 |
4 |
B |
$14.00 |
$140,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-02-10 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-02-10 |
4 |
AS |
$14.42 |
$216,300 |
D/D |
(15,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-04-14 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-04-14 |
4 |
AS |
$9.69 |
$145,350 |
D/D |
(15,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-05-19 |
4 |
AS |
$9.00 |
$135,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-05-19 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-06-17 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-06-17 |
4 |
AS |
$12.28 |
$184,226 |
D/D |
(15,000) |
0 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-07-18 |
4 |
OE |
$0.87 |
$34,800 |
D/D |
40,000 |
40,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-07-18 |
4 |
AS |
$10.61 |
$159,102 |
D/D |
(15,000) |
25,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-08-05 |
4 |
OE |
$0.87 |
$21,750 |
D/D |
25,000 |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-08-20 |
4 |
AS |
$11.59 |
$115,900 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-08-20 |
4 |
OE |
$0.87 |
$8,700 |
D/D |
10,000 |
60,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-09-17 |
4 |
OE |
$0.87 |
$8,700 |
D/D |
10,000 |
60,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-09-17 |
4 |
AS |
$18.00 |
$180,000 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-09-23 |
4 |
OE |
$2.03 |
$20,300 |
D/D |
10,000 |
60,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2014-09-23 |
4 |
AS |
$18.47 |
$184,660 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-01-20 |
4 |
AS |
$36.59 |
$1,248,972 |
D/D |
(34,135) |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-01-20 |
4 |
OE |
$0.87 |
$132,144 |
D/D |
34,135 |
84,135 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-02-02 |
4 |
OE |
$7.94 |
$79,400 |
D/D |
10,000 |
60,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-02-02 |
4 |
AS |
$35.09 |
$352,916 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-03-02 |
4 |
OE |
$7.94 |
$79,400 |
D/D |
10,000 |
60,537 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-03-02 |
4 |
AS |
$38.90 |
$396,546 |
D/D |
(10,000) |
50,537 |
0 |
- |
|
TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
|
2015-03-26 |
4 |
OE |
$0.87 |
$17,400 |
D/D |
20,000 |
70,537 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|